Notes Payable and Convertible Notes Payable (Details Narrative) - USD ($)	3 Months Ended
	Jun. 30, 2015	Mar. 31, 2015	Sep. 30, 2014
Debt Disclosure [Abstract]
Convertible notes, annual interest rate	12.00%
Convertible notes, conversion price	$ .15
Unamortized discount on convertible notes outstanding	$ 222,581		$ 0
Convertible notes issued by Regen Biopharma		$ 882,686
Cash consideration for issued notes by Regen Biopharma	90,000	775,000
Satisfaction of existing indebtedness		$ 107,686
Common shares issued upon conversion of notes payable		31,539,262
Series A preferred shares issued upon conversion of notes payable		31,538,862
Derivative liability	350,666	$ 2,368,685
Convertible notes issued	$ 90,000
Common stock issued in satisfaction of convertible debt	3,214,285